Zentiva, a Czechia-based generics pharmaceutical company, announced on Friday that it has received the ESG Transparency Award 2025, presented by German market research organisation EUPD Group at the ESG Summit 2025.
The award aims to recognise companies that excel in clarity, structure and transparency in their Environmental, Social and Governance (ESG) reporting.
EUPD Group said that Zentiva was awarded the Excellence Level of the ESG Transparency Award for its high degree of clarity, accessibility and transparency in sustainability reporting. This distinction places the company among the top organisations in Europe in terms of transparent reporting of its ESG disclosures.
Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide
Mendus reports trial follow-up data supporting potential of vididencel in high-risk ovarian cancer
Novo Nordisk submits sNDA to FDA for for higher semaglutide injection dose
SK Biopharmaceuticals signs licence agreement with Wisconsin Alumni Research Foundation
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15